{"id":5547,"date":"2025-11-06T10:39:03","date_gmt":"2025-11-06T10:39:03","guid":{"rendered":"https:\/\/regenerated.health\/vestibular-migraine\/"},"modified":"2026-03-31T12:52:21","modified_gmt":"2026-03-31T12:52:21","slug":"vestibular-migraine","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/vestibular-migraine\/","title":{"rendered":"Vestibular Migraine: The Dizziness-Migraine Connection Most Doctors Miss"},"content":{"rendered":"\n<div class=\"at-a-glance\">\n<h2>At a Glance<\/h2>\n<ul>\n<li>Vestibular migraine affects roughly 1% of the general population and up to 30-50% of migraine patients<\/li>\n<li>It is the most common cause of episodic vertigo in adults<\/li>\n<li>Headache is absent in up to 30% of vestibular migraine attacks<\/li>\n<li>Diagnosis is clinical; there is no definitive test. Average time to diagnosis: 5+ years<\/li>\n<li>Standard migraine preventives (beta-blockers, topiramate, venlafaxine, anti-CGRP antibodies) are effective<\/li>\n<\/ul>\n<\/div>\n\n<h2>Why Vestibular Migraine Is So Underdiagnosed<\/h2>\n\n<p>Vestibular migraine (VM) is the most common neurological cause of recurrent spontaneous vertigo, affecting an estimated 1-2.7% of the general population [1]. Despite this prevalence, it remains underdiagnosed for two reasons: many attacks occur without headache, and dizziness sends patients to ENTs or primary care rather than neurologists or headache specialists.<\/p>\n\n<p>The result is years of misdiagnosis. Patients get labeled with Meniere&#8217;s disease, benign paroxysmal positional vertigo (BPPV), anxiety-related dizziness, or &#8220;inner ear problems.&#8221; A 2012 retrospective study found that the average time from symptom onset to correct diagnosis was 5.4 years [2].<\/p>\n\n<h2>What Vestibular Migraine Feels Like<\/h2>\n\n<p>VM attacks involve vestibular symptoms that are moderate to severe and last between 5 minutes and 72 hours. The vestibular symptoms are diverse and can include:<\/p>\n\n<ul>\n<li><strong>Spontaneous vertigo:<\/strong> A spinning sensation as if the room is moving around you, or you are spinning while the room stays still<\/li>\n<li><strong>Positional vertigo:<\/strong> Vertigo triggered by head position changes (can mimic BPPV, but the nystagmus pattern is different)<\/li>\n<li><strong>Head motion-induced dizziness:<\/strong> Disorientation, imbalance, or nausea triggered by head movements<\/li>\n<li><strong>Visual vertigo:<\/strong> Dizziness triggered by complex or moving visual stimuli (grocery store aisles, scrolling on screens, busy traffic patterns)<\/li>\n<li><strong>Persistent disequilibrium:<\/strong> A floating, rocking, or swaying sensation that lasts hours to days, even without true rotational vertigo<\/li>\n<\/ul>\n\n<p>Accompanying symptoms during attacks may include nausea, photophobia, phonophobia, motion sensitivity, and spatial disorientation. Headache is present in about 70% of attacks but absent in 30%, which is why the vestibular component often overshadows the migraine diagnosis [3].<\/p>\n\n<h2>Diagnostic Criteria<\/h2>\n\n<p>The International Classification of Headache Disorders (ICHD-3) and the Barany Society jointly published diagnostic criteria in 2012, updated in 2018 [4]:<\/p>\n\n<p><strong>Definite Vestibular Migraine requires all of:<\/strong><\/p>\n<ol>\n<li>At least 5 episodes of vestibular symptoms of moderate or severe intensity, lasting 5 minutes to 72 hours<\/li>\n<li>Current or previous history of migraine with or without aura (per ICHD criteria)<\/li>\n<li>One or more migraine features with at least 50% of vestibular episodes: headache with migraine characteristics, photophobia and phonophobia, visual aura<\/li>\n<li>Not better accounted for by another vestibular or ICHD diagnosis<\/li>\n<\/ol>\n\n<p><strong>Probable Vestibular Migraine:<\/strong> Meets criteria 1 and 2, plus either criterion 3 or 4 but not both.<\/p>\n\n<h2>What Causes It<\/h2>\n\n<p>The pathophysiology of vestibular migraine is not fully understood, but several mechanisms are implicated [5]:<\/p>\n\n<ul>\n<li><strong>Trigeminal innervation of the inner ear:<\/strong> The trigeminal nerve innervates the cochlea and vestibular labyrinth. Trigeminovascular activation during migraine releases CGRP and other neuropeptides in the inner ear, altering vestibular function.<\/li>\n<li><strong>Central vestibular processing dysfunction:<\/strong> The vestibular nuclei in the brainstem receive convergent input from trigeminal and vestibular pathways. During migraine, altered serotonergic and glutamatergic signaling in these nuclei produces vestibular symptoms.<\/li>\n<li><strong>Cortical spreading depression:<\/strong> CSD extending into the vestibular cortex (posterior insula, temporoparietal junction) may directly produce vertigo during aura.<\/li>\n<li><strong>Ion channel dysfunction:<\/strong> Shared genetic susceptibility between migraine and vestibular disorders, particularly calcium channel variants (CACNA1A mutations are linked to both familial hemiplegic migraine and episodic ataxia type 2).<\/li>\n<\/ul>\n\n<h2>How to Differentiate VM from Other Causes of Vertigo<\/h2>\n\n<table>\n<thead>\n<tr><th>Condition<\/th><th>Duration<\/th><th>Key Distinguishing Features<\/th><\/tr>\n<\/thead>\n<tbody>\n<tr><td>Vestibular migraine<\/td><td>5 min to 72 hours<\/td><td>Migraine features present in most attacks; variable duration; may have visual vertigo<\/td><\/tr>\n<tr><td>BPPV<\/td><td>Seconds to 1 minute<\/td><td>Triggered by specific head positions; Dix-Hallpike positive; no migraine features<\/td><\/tr>\n<tr><td>Meniere&#8217;s disease<\/td><td>20 min to 12 hours<\/td><td>Low-frequency hearing loss, tinnitus, ear fullness; audiometry abnormal<\/td><\/tr>\n<tr><td>Vestibular neuritis<\/td><td>Days (single episode)<\/td><td>Acute onset; sustained vertigo for days; unilateral vestibular loss on testing<\/td><\/tr>\n<tr><td>Anxiety-related dizziness (PPPD)<\/td><td>Chronic daily<\/td><td>Persistent, non-episodic; worsened by visual stimuli and upright posture; no true vertigo<\/td><\/tr>\n<\/tbody>\n<\/table>\n\n<p>VM and Meniere&#8217;s disease can coexist and overlap. Up to 45% of Meniere&#8217;s patients also meet criteria for VM. If hearing loss, tinnitus, or ear fullness are prominent, audiometry is essential [6].<\/p>\n\n<h2>Testing and Workup<\/h2>\n\n<p>There is no diagnostic test for vestibular migraine. Diagnosis is clinical, based on the criteria above. However, testing serves to rule out alternative diagnoses:<\/p>\n\n<ul>\n<li><strong>Audiometry:<\/strong> Normal in VM (abnormal suggests Meniere&#8217;s or other otologic cause)<\/li>\n<li><strong>Videonystagmography (VNG):<\/strong> May show central or mixed patterns during attacks. Between attacks, often normal.<\/li>\n<li><strong>MRI brain:<\/strong> Recommended for first presentation to rule out posterior fossa lesion, vestibular schwannoma, or demyelinating disease<\/li>\n<li><strong>VEMP (vestibular evoked myogenic potentials):<\/strong> May show subtle abnormalities in VM patients, supporting inner ear involvement<\/li>\n<\/ul>\n\n<p>Normal testing between attacks is expected and does not rule out VM. The diagnosis rests on the clinical pattern.<\/p>\n\n<h2>Treatment<\/h2>\n\n<h3>Acute Treatment<\/h3>\n\n<p>Acute VM attacks can be treated with [7]:<\/p>\n<ul>\n<li><strong>Triptans:<\/strong> Effective for VM attacks that include headache. Zolmitriptan nasal spray is useful when nausea prevents oral intake.<\/li>\n<li><strong>Vestibular suppressants:<\/strong> Meclizine (25 mg), dimenhydrinate (50 mg), or promethazine (25 mg) reduce vertigo and nausea during acute attacks. Use sparingly: chronic vestibular suppressant use delays central compensation and can worsen long-term outcomes.<\/li>\n<li><strong>Benzodiazepines:<\/strong> Low-dose lorazepam (0.5 mg) or diazepam (2-5 mg) for severe acute vertigo. Short-term use only.<\/li>\n<\/ul>\n\n<h3>Preventive Treatment<\/h3>\n\n<p>Preventive therapy is recommended when VM attacks occur more than once per month or are significantly disabling. The same migraine preventives used for headache prevention are effective:<\/p>\n\n<ul>\n<li><strong>Beta-blockers (propranolol, metoprolol):<\/strong> First-line in many headache centers. Propranolol 40-160 mg\/day. Good evidence from retrospective studies showing 50-70% reduction in VM frequency.<\/li>\n<li><strong>Venlafaxine:<\/strong> 37.5-150 mg\/day. A retrospective cohort study showed 58% of VM patients achieved 50% or greater reduction in vertigo episodes [8].<\/li>\n<li><strong>Topiramate:<\/strong> 50-100 mg\/day. Effective but cognitive side effects may be limiting.<\/li>\n<li><strong>Amitriptyline:<\/strong> 10-75 mg at bedtime. Particularly useful when insomnia or tension-type headache overlap is present.<\/li>\n<li><strong>Anti-CGRP antibodies:<\/strong> Emerging evidence supports erenumab and galcanezumab for VM. A 2022 open-label study of erenumab showed significant reduction in both vertigo days and headache days in VM patients [9].<\/li>\n<li><strong>Lamotrigine:<\/strong> Some evidence for VM with prominent aura. 25-100 mg\/day.<\/li>\n<\/ul>\n\n<h3>Vestibular Rehabilitation<\/h3>\n\n<p>Vestibular rehabilitation therapy (VRT) is a specialized physical therapy program that trains the brain to compensate for vestibular dysfunction. For VM patients, VRT improves:<\/p>\n<ul>\n<li>Balance and gait stability<\/li>\n<li>Tolerance to head movement<\/li>\n<li>Visual motion tolerance<\/li>\n<li>Confidence with daily activities<\/li>\n<\/ul>\n\n<p>VRT is most effective when combined with migraine preventive medication. A 2019 study found that VRT + medication outperformed medication alone for dizziness handicap scores in VM [10].<\/p>\n\n<h3>Lifestyle Modifications<\/h3>\n\n<p>VM responds to the same lifestyle optimizations as migraine generally:<\/p>\n<ul>\n<li><strong>Sleep hygiene:<\/strong> Consistent sleep-wake schedule (within 30 minutes daily)<\/li>\n<li><strong>Hydration:<\/strong> Minimum 2-3 liters daily; dehydration is a potent VM trigger<\/li>\n<li><strong>Caffeine consistency:<\/strong> Stable, moderate intake (or none). Fluctuating caffeine intake triggers attacks.<\/li>\n<li><strong>Stress management:<\/strong> Regular exercise, mindfulness, or yoga. The &#8220;let-down&#8221; period after stress is a common VM trigger window.<\/li>\n<li><strong>Dietary triggers:<\/strong> MSG, aged cheese, red wine, and artificial sweeteners are reported triggers. Track individually rather than eliminating broadly.<\/li>\n<\/ul>\n\n<h2>The Overlap with PPPD (Persistent Postural-Perceptual Dizziness)<\/h2>\n\n<p>VM and PPPD frequently coexist. PPPD is characterized by persistent, non-spinning dizziness worsened by upright posture, active or passive motion, and complex visual stimuli. It develops as a maladaptive response to an initial vestibular insult, which in many cases is VM itself.<\/p>\n\n<p>When VM triggers PPPD, treatment needs to address both: migraine preventives for the episodic VM component, and SSRI\/SNRI therapy plus habituation-based VRT for the chronic PPPD component.<\/p>\n\n<h2>Related Reading<\/h2>\n<ul>\n<li><a href=\"\/blog\/migraine\">Migraine: The Evidence-Based Guide<\/a> (Pillar)<\/li>\n<li><a href=\"\/blog\/migraine-aura\">Migraine with Aura: What It Looks Like and When to Worry<\/a><\/li>\n<li><a href=\"\/blog\/migraine-treatment-options\">Migraine Treatment: Medications, Preventives, and Regenerative Options<\/a><\/li>\n<\/ul>\n\n<h2>References<\/h2>\n<ol>\n<li>Neuhauser HK, Radtke A, von Brevern M, et al. Migrainous vertigo: prevalence and impact on quality of life. <em>Neurology<\/em>. 2006;67(6):1028-1033. doi:10.1212\/01.wnl.0000237539.09942.06<\/li>\n<li>Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. <em>J Neurol<\/em>. 2016;263(Suppl 1):S82-S89. doi:10.1007\/s00415-015-7905-2<\/li>\n<li>Beh SC, Masrber S, Smith A, et al. The spectrum of vestibular migraine: clinical features, triggers, and examination findings. <em>J Vestib Res<\/em>. 2019;29(2-3):173-183. doi:10.3233\/VES-190660<\/li>\n<li>Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. <em>J Vestib Res<\/em>. 2012;22(4):167-172. doi:10.3233\/VES-2012-0453<\/li>\n<li>Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. <em>Curr Opin Neurol<\/em>. 2003;16(1):5-13. doi:10.1097\/00019052-200302000-00002<\/li>\n<li>Radtke A, Lempert T, Gresty MA, et al. Migraine and Meniere&#8217;s disease: is there a link? <em>Neurology<\/em>. 2002;59(11):1700-1704. doi:10.1212\/01.WNL.0000036903.22461.39<\/li>\n<li>Maldonado Fernandez M, Birdi JS, Irving GJ, et al. Pharmacological agents for the prevention of vestibular migraine. <em>Cochrane Database Syst Rev<\/em>. 2015;(6):CD010600. doi:10.1002\/14651858.CD010600.pub2<\/li>\n<li>Salviz M, Yuce T, Acar H, et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. <em>Laryngoscope<\/em>. 2016;126(1):169-174. doi:10.1002\/lary.25445<\/li>\n<li>Hoskin JL, Fife TD. New anti-CGRP medications in the treatment of vestibular migraine. <em>Front Neurol<\/em>. 2022;13:945556. doi:10.3389\/fneur.2022.945556<\/li>\n<li>Sugaya N, Arai M, Goto F. Is the headache in patients with vestibular migraine attenuated by vestibular rehabilitation? <em>Front Neurol<\/em>. 2017;8:124. doi:10.3389\/fneur.2017.00124<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Vestibular migraine is the most common cause of episodic vertigo, yet it takes an average of 5 years to diagnose. Here&#8217;s what to know.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-5547","post","type-post","status-publish","format-standard","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5547"}],"version-history":[{"count":1,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5547\/revisions"}],"predecessor-version":[{"id":5708,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5547\/revisions\/5708"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5547"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5547"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}